Pergola, V.; Mattesi, G.; Cozza, E.; Pradegan, N.; Tessari, C.; Dellino, C.M.; Savo, M.T.; Amato, F.; Cecere, A.; Perazzolo Marra, M.; Tona, F.; Guaricci, A.I.; De Conti, G.; Gerosa, G.; Iliceto, S.; Motta, R. New Non-Invasive Imaging Technologies in Cardiac Transplant Follow-Up: Acquired Evidence and Future Options. Diagnostics2023, 13, 2818.
Pergola, V.; Mattesi, G.; Cozza, E.; Pradegan, N.; Tessari, C.; Dellino, C.M.; Savo, M.T.; Amato, F.; Cecere, A.; Perazzolo Marra, M.; Tona, F.; Guaricci, A.I.; De Conti, G.; Gerosa, G.; Iliceto, S.; Motta, R. New Non-Invasive Imaging Technologies in Cardiac Transplant Follow-Up: Acquired Evidence and Future Options. Diagnostics 2023, 13, 2818.
Pergola, V.; Mattesi, G.; Cozza, E.; Pradegan, N.; Tessari, C.; Dellino, C.M.; Savo, M.T.; Amato, F.; Cecere, A.; Perazzolo Marra, M.; Tona, F.; Guaricci, A.I.; De Conti, G.; Gerosa, G.; Iliceto, S.; Motta, R. New Non-Invasive Imaging Technologies in Cardiac Transplant Follow-Up: Acquired Evidence and Future Options. Diagnostics2023, 13, 2818.
Pergola, V.; Mattesi, G.; Cozza, E.; Pradegan, N.; Tessari, C.; Dellino, C.M.; Savo, M.T.; Amato, F.; Cecere, A.; Perazzolo Marra, M.; Tona, F.; Guaricci, A.I.; De Conti, G.; Gerosa, G.; Iliceto, S.; Motta, R. New Non-Invasive Imaging Technologies in Cardiac Transplant Follow-Up: Acquired Evidence and Future Options. Diagnostics 2023, 13, 2818.
Abstract
Heart transplantation (HT) represents the mainstream therapy of end-stage heart failure for selected patients with a median survival of more than 10 years after surgery and substantial improvement in quality of life. Current guidelines suggest a variety of examinations including invasive (coronary angiography and endomyocardial biopsy (EBM) and non-invasive methods (echocardiography, stress echocardiography, computed tomography, PET and MRI) to monitor HT patients. Guidelines do not specify the timing of echocardiographic evaluations and do not recommend echocardiography as an alternative to serial EMB in rejection monitoring [2]. They still recommend as gold standard coronary angiography to be done 1 year after surgery and every 2 years after. In this review we will discuss the advantages of non-invasive techniques over the invasive ones for an adequate follow-up of HT patients.
Medicine and Pharmacology, Cardiac and Cardiovascular Systems
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.